Opexa (Bilastine)

Bilastine, the active ingredient in Opexa, is an antihistamine presented as a formulation for ocular use. It treats allergic eye conditions and related symptoms in patients requiring antihistamine therapy. GNH USA supplies Opexa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bilastine acts on histamine‑mediated allergic pathways to relieve symptoms of several allergic disorders.

- Allergic conjunctivitis: reduces eye itching, redness and tearing. - Seasonal allergic rhinitis: alleviates nasal congestion, sneezing and itching. - Chronic idiopathic urticaria: diminishes wheal formation and pruritus.

Bilastine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate discomfort. - Drowsiness: occasional sleepiness, especially at higher exposure. - Dry mouth: reduced salivation. - Nausea: transient stomach upset. - Fatigue: feeling of reduced energy. - Dizziness: brief light‑headedness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Angioedema: swelling of face, lips or tongue. - Hepatic injury: abnormal liver function tests. - Cardiac arrhythmia: irregular heart rhythm in susceptible individuals. - Severe cutaneous adverse reactions: including toxic epidermal necrolysis.

When using Bilastine, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: weigh benefits against potential infant exposure. - Driving or operating machinery: avoid if drowsiness occurs. - Concomitant CNS depressants: monitor for additive sedation. - Renal impairment: dose adjustment may be required. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Bilastine may interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Ketoconazole: may increase Bilastine plasma levels. - Erythromycin: can raise systemic exposure. - Ritonavir: potent CYP3A4 inhibition may elevate concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance drowsiness. - Other antihistamines: additive sedation possible. - CNS depressants: monitor for increased central effects. - Antacids: may reduce absorption if taken simultaneously.